Fructooligosaccharides Set
| Grade : | for HPLC |
| Specification Assay : | 99.0+% (HPLC)(1-Kestose), 99.0+% (HPLC)(Nystose), 80.0+% (HPLC)(1F-Fructofuranosylnystose) |
| Storage Condition : | Keep at RT. |
Manufacturer : FUJIFILM Wako Pure Chemical Corporation
| Catalogue/Product Number | Package Size | COA Download |
|---|---|---|
|
295-73401
|
1Set |
×
Document
Overview
Fructooligosaccharides are indigestible oligosaccharides that are made from sugar and produced by the action of enzymes. It has a structure in which 2 to 4 molecules of fructose are bound to glucose.
Fructooligosaccharides are selectively assimilated by useful intestinal bacteria such as bifidobacteria, and have low cariogenicity, an effect of improving constipation, and an effect of inhibiting intestinal rot. It is designated as a food for specified insurance.
Features
- Intestinal function
It has the effects of improving constipation and suppressing intestinal putrefaction. - Prebiotic effect
It has a prebiotic effect that keeps good bacteria such as bifidobacterium predominant and improves the balance of intestinal flora. Furthermore, when bifidobacteria grows, short-chain fatty acids are produced and the pH in the large intestine decreases. As a result, the solubility of minerals is increased and absorption into cells is promoted. - Low cariogenicity
It is not used for mutans, which is the causative agent of tooth decay. It is selectively assimilated by useful intestinal bacteria such as bifidobacterium. Therefore, it produces almost no insoluble glucan that causes dental plaque, and has the property of being less likely to cause tooth decay. - Improvement of immunity
It has been reported that the expression of the intestinal immunoregulatory marker gene is enhanced and the intestinal immunity is enhanced. - Indigestibility
Since it reaches the large intestine without being digested and absorbed in the human digestive tract, the caloric intake can be reduced and suppresses the blood sugar elevation. - Improvement of lipid metabolism
It has been reported that the expression of a marker gene for improving lipid metabolism is enhanced and blood cholesterol level is lowered.
- Intestinal function
HPLC Analysis
HPLC
Column : Wakopak® Wakosil 5NH2, 4.6 x 250 mm
(Code No. : 238-57691, 234-57693)Column temperature : 40℃ Eluent : CH3CN : H2O=70 : 30 Flow rate : 1.5 mL/min Detection : RI Injection : 10 mg/mL, 10 μL
Overview / Applications
| Outline | This product is for research use only. Do not administer it to human.
|
|---|---|
| Precautions for Use | Packed on argon gas |
Property
| Appearance | White, crystals - powder(1-Kestose), White, crystalline powder - powder(Nystose), White, crystalline powder - powder(1F-Fructofuranosylnystose) |
|---|---|
| Specific Rotation | +27.0 - +32.0 degrees (D/20 degrees C)(c=5,H2O)(1-Kestose) +10.0 - +11.5 degrees (D/20 degrees C)(c=5,H2O)(Nystose) 0 - -5.0 degrees (D/20 degrees C)(c=5,H2O)(1F-Fructofuranosylnystose) |